Anavex Life Sciences Corp (AVXL)

[RedShoulder]

ACADIA Pharmaceuticals (ACAD) obtained FDA approval for their Rett drug on March 11th; and that is a Saturday which is not a good day to release good news. The dive you see on the chart started Thursday (leak) and is fairly steep. It went red on a deep V dive after the open 20.10 to 18.73 and is currently 19,58 and down .82 with a -4% loss now. I think that was a result of "sell on the news" and more importantly IMO is that the investors see Anavex 2-73 Blarcamesine taking the market once approved. Then there is the side effects of diarrhea and vomiting, and improvements are below 2-73 better results on adults.

Chart:
https://finance.yahoo.com/quote/ACAD?p=ACAD&.tsrc=fin-srch